Qkine secures additional £550K to extend development of R&D pipeline and accelerate commercialisation of product portfolio

Cambridge, UK 03 June 2019: Qkine, specialist manufacturer of proteins for stem cell, organoid and regenerative medicine applications has closed a further round of investment. The £550k funding round was led by Cambridge Enterprise and five angel investors – all of whom followed initial seed investments made in April 2018. Joining the original investors [...]

By |2019-06-03T07:58:35+00:00June 3rd, 2019|news, press release|Comments Off on Qkine secures additional £550K to extend development of R&D pipeline and accelerate commercialisation of product portfolio

Qkine backed by Cambridge Enterprise and a quintet of angels

University of Cambridge spin-out Qkine has closed its seed investment round supported by Cambridge Enterprise, the commercialisation arm of the University, and a team of five angels led by Jim Warwick. The amount is undisclosed. Qkine is a specialist manufacturer of proteins that are used for control of stem cell growth and differentiation. The backing [...]

By |2018-04-23T13:13:44+00:00April 23rd, 2018|news, press release|Comments Off on Qkine backed by Cambridge Enterprise and a quintet of angels